logo
Beyond the numbers
Atrial fibrillation in the setting of acute myocardial infarction —irregularly irregular treatment
Epidemiology and risk stratification in acute heart failure
The clinical need for high-sensitivity cardiac troponin assays for acute coronary syndromes and the role for serial testing
Design of the Future REvascularization Evaluation in patients with Diabetes mellitus
Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) Trial
Geometry of the proximal isovelocity surface area in mitral regurgitation by 3-dimensional color Doppler echocardiography
Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapy
A 6 month randomized, double blind, placebo controlled, multi-center trial of high dose atorvastatin on myocardial perfusion abnormalities by positron emission tomography in coronary artery disease
Correction
The prevalence of extracardiac findings by multidetector computed tomography before atrial fibrillation ablation
Serious renal dysfunction after percutaneous coronary interventions can be predicted
Impact of the New York State Cardiac Surgery and Percutaneous Coronary Intervention Reporting System on the management of patients with acute myocardial infarction complicated by cardiogenic shock
A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease
Impaired fasting glucose and outcomes of ST-elevation acute coronary syndrome treated with primary percutaneous intervention among patients without previously known diabetes mellitus
Correction
Treatment delay in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction
Effect of statin dose on incidence of atrial fibrillation
Interleukin-6 and atrial fibrillation in patients with coronary artery disease
Atrial fibrillation and obesity—results of a meta-analysis
Class effects of statins in elderly patients with congestive heart failure
Correction
Life expectancy after an index hospitalization for patients with heart failure
Heart failure disease management programs
Characteristics of “Stage D” heart failure
Lower extremity peripheral arterial disease in individuals with coronary artery disease
Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease
Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation
Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes
Angina with “normal” coronary arteries
Effect of ximelagatran on ischemic events and death in patients with atrial fibrillation after acute myocardial infarction in the efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with recent myocardial damage (ESTEEM∥ trial
Causes of death in patients with acute myocardial infarction treated with angiotensin-converting enzyme inhibitors
Reply
Caveats in determining reference intervals for serum creatine kinase
High-sensitivity C-reactive protein for risk stratification in patients with heart failure
Relationship of high sensitivity C reactive peptide (hsCRP∥ to prognosis and other prognostic markers in outpatients with heart failure
Does lead aVR contain prognostic information in patients with non-ST-elevation acute coronary syndromes?
Letter to the Editor
Cardiac defibrillators, Kant, and the categorical imperative
Cardiac defibrillators, Kant, and the categorical imperative